Showing 741-750 of 1010 results for "".
- Managing Employees During the COVID Pandemic: Answers to Top Questionshttps://modernaesthetics.com/news/managing-employees-in-the-covid-pandemic-answers-to-top-questions/2473040/Can I require staff to get a vaccine in order to continue working? In many cases, vaccines can be required, says Josh Alloy, JD, Counsel at Arnold and Porter in Washington, DC, “although there are potential e
- Revance Therapeutics and Ajinomoto Bio-Pharma Services Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injectionhttps://modernaesthetics.com/news/revance-therapeutics-and-ajinomoto-bio-pharma-services-announce-manufacturing-agreement-for-supply-of-daxibotulinumtoxina-for-injection/2473035/Ajinomoto Bio-Pharma Services will serve as a supply source and provide manufacturing for Revance Therapeutics, Inc.’s DaxibotulinumtoxinA for Injection. DaxibotulinumtoxinA for Injection is currently under Biologics License Application (BLA) review.
- Call for Entries: Merz Aesthetics Announces First-Ever Innovation Forumhttps://modernaesthetics.com/news/call-for-entries-merz-aesthetics-announces-first-ever-innovation-forum/2473021/Merz Aesthetics is launching its first-ever Innovation Forum with a call for abstract submissions seeking the most creative and inventive medical aesthetics abstracts from the next generation of researchers and healthcare professionals. The author of the winning abstrac
- SoftWave Tissue Regeneration Technologies Announces Plan for Cellulite Trialhttps://modernaesthetics.com/news/softwave-tissue-regeneration-technologies-announces-plan-for-cellulite-trial/2472974/SoftWave Tissue Regeneration Technologies plans to start a 60-patient study to evaluate the safety and efficacy of the DermaGold device for the temporary improvement in the appearance of cellulite. The company has a patent for the use
- Alastin Skincare Scores Another New Patenthttps://modernaesthetics.com/news/alastin-skincare-scores-another-new-patent/2472970/Alastin Skincare, Inc. received a fourth U.S. Patent from the United States Patent and Trademark Office. The new patent, which incorporates TriHex Technology, is directed to a topical composition for alleviating bruising caused by a cosmetic procedure—INhance Post-Injection Serum
- New Officers Announced at American Society for Laser Medicine and Surgeryhttps://modernaesthetics.com/news/new-officers-announced-at-american-society-for-laser-medicine-and-surgery/2472943/Thomas E. Rohrer, MD was introduced as President of the American Society for Laser Medicine and Surgery (ASLMS) during the Board of Directors meeting on April 30, 2020. ASLMS is the world's largest professional organization dedicated to promoting research, education, and high standards of cli
- Modern Aesthetics® Magazine’s Exclusive First Look at the Annual AAFPRS Survey Resultshttps://modernaesthetics.com/news/modern-aesthetics-magazines-exclusive-first-look-at-annual-aafprs-survey/2472881/Facial plastic surgery procedures increased 6 percent last year compared to 2018, according to the
- Meet Emtone: BTL's Answer to Cellulitehttps://modernaesthetics.com/news/meet-emtone-btls-answer-to-cellulite/2471875/Drumroll please…BTL is launching
- Galderma Announces Formation of Women in Aesthetics Leadership Councilhttps://modernaesthetics.com/news/galderma-announces-formation-of-women-in-aesthetics-leadership-council/2471960/Galderma Laboratories, L.P. is forming a Women in Aesthetics Leadership Council. The newly formed Council is comprised of clinicians, clinical trial investigators, CEOs, business owners, and practice managers. "In most industries in the U.S. wome
- Galderma Announces the Start of Six New Aesthetic Studieshttps://modernaesthetics.com/news/galderma-announces-the-start-of-six-new-aesthetic-studies/2472014/Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology products; two studies for Dysport evaluating patient satisfaction and